Intraventricular dyssynchrony in light chain amyloidosis: A new mechanism of systolic dysfunction assessed by 3-dimensional echocardiography

Cardiovascular Ultrasound

Volumn 6, Issue , 2008, Pages

  Migrino, Raymond Q ^a   Harmann, Leanne ^a   Woods, Timothy ^a   Bright, Megan ^a   Truran, Seth ^a   Hari, Parameswaran ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART DISEASE; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HUMAN; INTRAVENTRICULAR DYSSYNCHRONY; LIGHT CHAIN AMYLOIDOSIS; MALE; THREE DIMENSIONAL ECHOCARDIOGRAPHY; CARDIOMYOPATHY; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; SYSTOLE;

AMYLOIDOSIS; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; STROKE VOLUME; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 50249118246     PISSN: None     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-6-40     Document Type: Article

References (40)

1. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. V Sanchorawala DG Wright DC Seldin LM Dember K Finn RH Falk J Berk K Quillen M Skinner, Bone Marrow Transplant 2001 28 7 637 642 10.1038/sj.bmt.1703200 11704785
2. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. RL Comenzo E Vosburgh RW Simms P Bergethon D Sarnacki K Finn S Dubrey DV Faller DG Wright RH Falk M Skinner, Blood 1996 88 7 2801 2806 8839879
3. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. RA Kyle MA Gertz, Semin Hematol 1995 32 1 45 59 7878478
4. Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. A Dispenzieri MA Gertz RA Kyle MQ Lacy MF Burritt TM Therneau JP McConnell MR Litzow DA Gastineau A Tefferi DJ Inwards IN Micallef SM Ansell LF Porrata MA Elliott WJ Hogan SV Rajkumar R Fonseca PR Greipp TE Witzig JA Lust SR Zeldenrust DS Snow SR Hayman CG McGregor AS Jaffe, Blood 2004 104 6 1881 1887 10.1182/blood-2004-01-0390 15044258
5. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. AL Klein LK Hatle DJ Burstow JB Seward RA Kyle KR Bailey TF Luscher MA Gertz AJ Tajik, J Am Coll Cardiol 1989 13 5 1017 1026 2647814
6. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. AL Klein LK Hatle CP Taliercio CL Taylor RA Kyle KR Bailey JB Seward AJ Tajik, J Am Coll Cardiol 1990 16 5 1135 1141 2229760
7. Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J Koyama R Davidoff RH Falk, J Am Soc Echocardiogr 2004 17 1 36 44 10.1016/j.echo.2003.09.014 14712185
8. Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. J Koyama PA Ray-Sequin R Davidoff RH Falk, Am J Cardiol 2002 89 9 1067 1071 10.1016/S0002-9149(02)02277-4 11988197
9. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. AG Siqueira-Filho CL Cunha AJ Tajik JB Seward TT Schattenberg ER Giuliani, Circulation 1981 63 1 188 196 7438392
10. Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. S Ghio C Constantin C Klersy A Serio A Fontana C Campana L Tavazzi, Eur Heart J 2004 25 7 571 578 10.1016/j.ehj.2003.09.030 15120054
11. Left ventricular dysfunction is associated with intraventricular dyssynchrony by 3-dimensional echocardiography in children. GH Baker AM Hlavacek KS Chessa DM Fleming GS Shirali, J Am Soc Echocardiogr 2008 21 3 230 233 10.1016/j.echo.2007.08.046 17904813
12. The effect of cardiac resynchronization on morbidity and mortality in heart failure. JG Cleland JC Daubert E Erdmann N Freemantle D Gras L Kappenberger L Tavazzi, N Engl J Med 2005 352 15 1539 1549 10.1056/NEJMoa050496 15753115
13. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. JG Cleland JC Daubert E Erdmann N Freemantle D Gras L Kappenberger L Tavazzi, Eur Heart J 2006 27 16 1928 1932 10.1093/eurheartj/ ehl099 16782715
14. "Hypersynchronization" by Tissue Velocity Imaging in Patients with Cardiac Amyloidosis. D Bellavia PA Pellikka TP Abraham G Al-Zahrani A Dispenzieri J Oh RE Espinosa CG Scott C Miyazaki FA Miller Jr., Heart (British Cardiac Society) 2008 18474536
15. Assessment of left ventricular systolic synchronicity by real-time three-dimensional echocardiography in patients with dilated cardiomyopathy. X Zeng XH Shu CZ Pan RZ Chen K Cheng SZ Liu HZ Chen, Chinese medical journal 2006 119 11 919 924 16780771
16. Cardiovascular magnetic resonance in cardiac amyloidosis. AM Maceira J Joshi SK Prasad JC Moon E Perugini I Harding MN Sheppard PA Poole-Wilson PN Hawkins DJ Pennell, Circulation 2005 111 2 186 193 10.1161/01.CIR.0000152819. 97857.9D 15630027
17. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. H Vogelsberg H Mahrholdt CC Deluigi A Yilmaz EM Kispert S Greulich K Klingel R Kandolf U Sechtem, J Am Coll Cardiol 2008 51 10 1022 1030 10.1016/j.jacc.2007.10.049 18325442
18. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. NB Schiller PM Shah M Crawford A DeMaria R Devereux H Feigenbaum H Gutgesell N Reichek D Sahn I Schnittger, J Am Soc Echocardiogr 1989 2 5 358 367 2698218
19. Real-time three-dimensional echocardiography: a novel technique to quantify global left ventricular mechanical dyssynchrony. S Kapetanakis MT Kearney A Siva N Gall M Cooklin MJ Monaghan, Circulation 2005 112 7 992 1000 10.1161/CIRCULATIONAHA.104.474445 16087800
20. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. RB Devereux DR Alonso EM Lutas GJ Gottlieb E Campo I Sachs N Reichek, Am J Cardiol 1986 57 6 450 458 10.1016/0002-9149(86)90771-X 2936235
21. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. RM Lang M Bierig RB Devereux FA Flachskampf E Foster PA Pellikka MH Picard MJ Roman J Seward JS Shanewise SD Solomon KT Spencer MS Sutton WJ Stewart, J Am Soc Echocardiogr 2005 18 12 1440 1463 10.1016/j.echo.2005.10.005 16376782
22. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. JS Gottdiener J Bednarz R Devereux J Gardin A Klein WJ Manning A Morehead D Kitzman J Oh M Quinones NB Schiller JH Stein NJ Weissman, J Am Soc Echocardiogr 2004 17 10 1086 1119 15452478
23. The reliability of measuring physical characteristics of spiculated masses on mammography. MP Sampat GJ Whitman TW Stephens LD Broemeling NA Heger AC Bovik MK Markey, Br J Radiol 2006 79 Spec No 2 S134 40 10.1259/bjr/96723280 17209119
24. Fundamentals of biostatistics. B Rosner, Belmont, CA, Duxbury Press 2005
25. Statistical methods for assessing agreement between two methods of clinical measurement. JM Bland DG Altman, Lancet 1986 1 8476 307 310 2868172
26. Applying the right statistics: analyses of measurement studies. JM Bland DG Altman, Ultrasound Obstet Gynecol 2003 22 1 85 93 10.1002/uog.122 12858311
27. Current clinical applications of spectral tissue Doppler echocardiography (E/E' ratio) as a noninvasive surrogate for left ventricular diastolic pressures in the diagnosis of heart failure with preserved left ventricular systolic function. S Arques E Roux R Luccioni, Cardiovascular ultrasound 2007 5 16 17386087 10.1186/1476-7120-5-16
28. Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. SF Nagueh H Sun HA Kopelen KJ Middleton DS Khoury, J Am Coll Cardiol 2001 37 1 278 285 10.1016/S0735-1097(00)01056-1 11153752
29. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. SR Ommen RA Nishimura CP Appleton FA Miller JK Oh MM Redfield AJ Tajik, Circulation 2000 102 15 1788 1794 11023933
30. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. DW Sohn IH Chai DJ Lee HC Kim HS Kim BH Oh MM Lee YB Park YS Choi JD Seo YW Lee, J Am Coll Cardiol 1997 30 2 474 480 10.1016/S0735-1097(97)88335-0 9247521
31. Echocardiography in heart failure: applications, utility, and new horizons. JN Kirkpatrick MA Vannan J Narula RM Lang, J Am Coll Cardiol 2007 50 5 381 396 10.1016/j.jacc.2007.03.048 17662389
32. The systemic amyloidoses. RH Falk RL Comenzo M Skinner, N Engl J Med 1997 337 13 898 909 10.1056/NEJM199709253371306 9302305
33. Amyloidosis: review of 236 cases. RA Kyle ED Bayrd, Medicine 1975 54 4 271 299 10.1097/00005792-197507000-00001 1152671
34. Amyloidosis (AL). Clinical and laboratory features in 229 cases. RA Kyle PR Greipp, Mayo Clinic proceedings 1983 58 10 665 683 6353084
35. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. M Skinner V Sanchorawala DC Seldin LM Dember RH Falk JL Berk JJ Anderson C O'Hara KT Finn CA Libbey J Wiesman K Quillen N Swan DG Wright, Ann Intern Med 2004 140 2 85 93 14734330
36. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. SW Dubrey K Cha J Anderson B Chamarthi J Reisinger M Skinner RH Falk, Qjm 1998 91 2 141 157 10.1093/qjmed/91.2.141 9578896
37. Cardiac resynchronization therapy in patients with a narrow QRS complex. GB Bleeker ER Holman P Steendijk E Boersma EE van der Wall MJ Schalij JJ Bax, J Am Coll Cardiol 2006 48 11 2243 2250 10.1016/j.jacc.2006.07.067 17161254
38. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline. GB Bleeker SA Mollema ER Holman N Van de Veire C Ypenburg E Boersma EE van der Wall MJ Schalij JJ Bax, Circulation 2007 116 13 1440 1448 10.1161/CIRCULATIONAHA.106.677005 17785624
39. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. MR Bristow LA Saxon J Boehmer S Krueger DA Kass T De Marco P Carson L DiCarlo D DeMets BG White DW DeVries AM Feldman, N Engl J Med 2004 350 21 2140 2150 10.1056/NEJMoa032423 15152059
40. Diagnosis and management of the cardiac amyloidoses. RH Falk, Circulation 2005 112 13 2047 2060 10.1161/CIRCULATIONAHA.104.489187 16186440